NRIX Stock-Based Compensation
Nurix Therapeutics Inc · Stock-Based Compensation
NRIX Stock-Based Compensation
Latest reported$40.66Mperiod ending
NRIX TTM Stock-Based Comp ($510.00K → $40.66M)
TTM stock-based compensation
High-resolution chart · PNG
NRIX stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 40,655,000 | |
| 39,650,000 | |
| 38,647,000 | |
| 37,965,000 | |
| 37,387,000 | |
| 36,369,000 | |
| 34,829,000 | |
| 33,929,000 | |
| 33,445,000 | |
| 33,136,000 | |
| 33,014,000 | |
| 33,673,000 | |
| 33,946,000 | |
| 32,489,000 | |
| 30,541,000 | |
| 28,131,000 | |
| 24,677,000 | |
| 22,002,000 | |
| 19,171,000 | |
| 15,800,000 | |
| 13,493,000 | |
| 10,295,000 | |
| 6,825,000 | |
| 4,301,000 | |
| 1,932,000 | |
| 953,000 | |
| 584,000 | |
| 510,000 |